BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27

• Drug Development

  MYMETICS Corporation Announces Success of Its Preventive Vaccine Against HIV/AIDS and Commencement of European Phase 1 Human Clinical Trials

  February 9, 2009

   · 

  1 min read
• FDA

  AstraZeneca LP Secures Approval For Two New Dosage Strengths Of Atacand Plus

  February 9, 2009

   · 

  5 min read
• Business

  Two key Nominations for CELLECTIS SA: Professor José Alain Sahel Joins the Scientific Advisory Board and Professor Roger J. Hajjar joins the Board of Directors

  February 9, 2009

   · 

  5 min read
• Business

  Shire plc Full Year 2008 Results Date Notification - 19 February 2008

  February 9, 2009

   · 

  1 min read
• Business

  Lundbeck Inc. (formerly Ovation Pharmaceuticals) to Buy OVATION Pharmaceuticals (Acquired by Lundbeck in March 2009) (JOBS) for up to $900 Million in Cash

  February 9, 2009

   · 

  1 min read
• Barr Laboratories, Mylan Inc. Plan Generics of Shire plc’s Fosrenol Drug

  February 9, 2009

   · 

  2 min read